What question did this study set out to answer?

To determine the association between systemic glucocorticoid use and the risk of colorectal cancer, focusing on early-onset cases.

February 19, 2026

Systemic Glucocorticoid Use and Risk of Colorectal Cancer, Especially Early-Onset Type: A Nationwide Cohort Study.

Key Points

To determine the association between systemic glucocorticoid use and the risk of colorectal cancer, focusing on early-onset cases.
Conducted a nationwide cohort study
Analyzed systemic glucocorticoid use in the population
Identified high-risk groups for colorectal cancer
Evaluated risk-adapted screening needs
Systemic glucocorticoid use is linked to a higher risk of colorectal cancer
Particularly significant association observed for early-onset colorectal cancer
Identification of new high-risk groups for enhanced screening

Abstract

Our large-scale cohort study showed that systemic glucocorticoid use is associated with an increased risk of CRC, particularly EOCRC. This study also identifies new high-risk groups who are candidates for earlier, risk-adapted CRC screening or preventive interventions.

Systemic Glucocorticoid Use and Risk of Colorectal Cancer, Especially Early-Onset Type: A Nationwide Cohort Study.

Key Points

Abstract

Cite This Study

Also Consider

Also Consider